Jinhai Huo, Ph.D. - Publications

Affiliations: 
2013 Policy & Community Health The University of Texas School of Public Health 
Area:
Public Health, Nursing

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Huo J, Hong YR, Turner K, Chen C, Guo Y, Wilkie DJ, Bian J. Geographic variation in palliative care delivery among patients diagnosed with metastatic lung cancer in the USA: Medicare population-based study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 32495033 DOI: 10.1007/S00520-020-05549-Z  0.368
2020 Yadav S, Heller IW, Schaefer N, Salloum RG, Kittelson SM, Wilkie DJ, Huo J. The health care cost of palliative care for cancer patients: a systematic review. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 32440909 DOI: 10.1007/S00520-020-05512-Y  0.349
2020 Shah C, Hong YR, Bishnoi R, Ali A, Skelton WP, Dang LH, Huo J, Dang NH. Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer. Frontiers in Oncology. 10: 405. PMID 32296640 DOI: 10.3389/Fonc.2020.00405  0.374
2020 Yuan C, Xie Z, Bian J, Huo J, Daily K. Outcomes of primary endocrine therapy in elderly women with stage I-III breast cancer: a SEER database analysis. Breast Cancer Research and Treatment. PMID 32172303 DOI: 10.1007/S10549-020-05591-9  0.321
2020 Hong YR, Xie Z, Mainous AG, Huo J. Patient-Centered Medical Home and Up-To-Date on Screening for Breast and Colorectal Cancer. American Journal of Preventive Medicine. 58: 107-116. PMID 31862097 DOI: 10.1016/J.Amepre.2019.08.030  0.351
2020 Joseph V, Roach K, Booker S, Huo J, Yao Y, Chen X, Cook RL, Wilkie DJ. Abstract C003: Sociodemographic and clinical characteristics associated with worst pain intensity among cancer patients Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-C003  0.305
2019 Salloum RG, Huo J, Lee JH, Lee J, Dallery J, George T, Warren G. Tobacco and E-cigarette use among cancer survivors in the United States. Plos One. 14: e0226110. PMID 31815948 DOI: 10.1371/Journal.Pone.0226110  0.331
2019 Hong YR, Huo J, Desai R, Cardel M, Deshmukh AA. Excess Costs and Economic Burden of Obesity-Related Cancers in the United States. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 22: 1378-1386. PMID 31806194 DOI: 10.1016/J.Jval.2019.07.004  0.303
2019 Huo J, Hong YR, Turner K, Bian J, Grewal R, Wilkie DJ. Utilization pattern and service settings of palliative care for patients with metastatic non-small-cell lung cancer. Cancer. PMID 31449674 DOI: 10.1002/Cncr.32478  0.376
2019 Zhao Y, Huo J, Prosperi M, Guo Y, Li Y, Bian J. Exploring Lung Cancer Screening Discussions on Twitter. Studies in Health Technology and Informatics. 264: 2011-2012. PMID 31438454 DOI: 10.3233/Shti190760  0.337
2019 Modave F, Zhao Y, Krieger J, He Z, Guo Y, Huo J, Prosperi M, Bian J. Understanding Perceptions and Attitudes in Breast Cancer Discussions on Twitter. Studies in Health Technology and Informatics. 264: 1293-1297. PMID 31438134 DOI: 10.3233/Shti190435  0.331
2019 Huo J, Chung TH, Kim B, Deshmukh AA, Salloum RG, Bian J. Provider-Patient Discussions About Smoking and the Impact of Lung Cancer Screening Guidelines: NHIS 2011-2015. Journal of General Internal Medicine. PMID 31228049 DOI: 10.1007/S11606-019-05111-6  0.321
2019 Hong YR, Smith GL, Xie Z, Mainous AG, Huo J. Financial burden of cancer care under the Affordable Care Act: Analysis of MEPS-Experiences with Cancer Survivorship 2011 and 2016. Journal of Cancer Survivorship : Research and Practice. PMID 31183677 DOI: 10.1007/S11764-019-00772-Y  0.36
2019 Bishnoi R, Hong YR, Shah C, Ali A, Skelton WP, Huo J, Dang NH, Dang LH. Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study. Cancer Medicine. PMID 31124302 DOI: 10.1002/Cam4.2278  0.323
2019 Huo J, Hong YR, Bian J, Guo Y, Wilkie DJ, Mainous AG. Low Rates of Patient-Reported Physician-Patient Discussion about Lung Cancer Screening among Current Smokers: Data from Health Information National Trends Survey. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31023697 DOI: 10.1158/1055-9965.Epi-18-0629  0.363
2019 Turner K, Hong YR, Yadav S, Huo J, Mainous AG. Patient portal utilization: before and after stage 2 electronic health record meaningful use. Journal of the American Medical Informatics Association : Jamia. PMID 30947331 DOI: 10.1093/Jamia/Ocz030  0.303
2019 Huo J, Hong YR, Grewal R, Yadav S, Heller IW, Bian J, Wilkie DJ. Knowledge of Palliative Care among American Adults: 2018 Health Information National Trends Survey. Journal of Pain and Symptom Management. PMID 30922703 DOI: 10.1016/J.Jpainsymman.2019.03.014  0.32
2019 Huo J, Xu Y, Sheu T, Volk RJ, Shih YT. Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting. Jama Internal Medicine. PMID 30640382 DOI: 10.1001/Jamainternmed.2018.6277  0.318
2019 Shah C, Hong Y, Bishnoi R, ali a, Skelton WP, Dang LH, Huo J, Dang NH. DPP4 inhibitors as novel agents in improving survival in patients with prostate cancer: A SEER-Medicare study. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E16532  0.309
2019 Bishnoi R, Hong Y, Shah C, ali a, Skelton WP, Huo J, Dang NH, Dang LH. DDP4 inhibitors as novel agents in improving survival in diabetic patients with CRC and lung cancer: A SEER-Medicare study. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E14633  0.307
2018 Huo J, Ray-Zack MD, Shan Y, Chamie K, Boorjian SA, Kerr P, Jana B, Freedland SJ, Kamat AM, Mehta HB, Williams SB. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer. European Urology Oncology. PMID 31411998 DOI: 10.1016/J.Euo.2018.07.009  0.374
2018 Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J, Senagore AJ, Orihuela E, Tyler DS, Swanson TA, Kamat AM. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer. Jama Surgery. PMID 29955780 DOI: 10.1001/Jamasurg.2018.1680  0.354
2018 Jazzar U, Yong S, Klaassen Z, Huo J, Hughes BD, Esparza E, Mehta HB, Kim SP, Tyler DS, Freedland SJ, Kamat AM, Wolf DV, Williams SB. Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States. Cancer. PMID 29660813 DOI: 10.1002/Cncr.31404  0.363
2018 Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J(, Orihuela E, Tyler DS, Swanson TA, Kamat AM. Survival outcomes and costs of trimodal therapy compared with radical cystectomy among patients diagnosed with localized muscle-invasive bladder cancer. Journal of Clinical Oncology. 36: 421-421. DOI: 10.1200/JCO.2018.36.6_suppl.421  0.317
2018 Williams S, Tabayoyong W, Shan Y, Jazzar U, Mehta H, Baillargeon J, Huo J, Senagore A, Orihuela E, Tyler D, Swanson T, Kamat A. Radical cystectomy provides improved survival outcomes and decreased costs compared with trimodal therapy for patients diagnosed with localized muscle-invasive bladder cancer European Urology Supplements. 17: e515. DOI: 10.1016/J.Juro.2018.02.630  0.382
2018 Kosarek C, Jazzar U, Shan Y, Klaassen Z, Huo J, Esparza E, Mehta H, Kuo Y, Kim S, Tyler D, Freedland S, Kamat A, Wolf D, Williams S. PD11-01 IMPACT OF POST-TREATMENT PSYCHIATRIC ILLNESS ON SURVIVAL OUTCOMES FOLLOWING TREATMENT FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.624  0.318
2017 Yue J, McKeever M, Sio TT, Xu T, Huo J, Shi Q, Nguyen QN, Komaki R, Gomez DR, Pan T, Wang XS, Liao Z. Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer. Clinical and Translational Radiation Oncology. 4: 1-7. PMID 29594201 DOI: 10.1016/J.Ctro.2017.04.001  0.308
2017 Williams SB, Huo J, Chu Y, Baillargeon JG, Daskivich T, Kuo YF, Kosarek CD, Kim SP, Orihuela E, Tyler DS, Freedland SJ, Kamat AM. Cancer and All-Cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-Making. Urology. PMID 28847688 DOI: 10.1016/J.Urology.2017.08.024  0.364
2017 Ning MS, Tang L, Gomez DR, Xu T, Luo Y, Huo J, Mouhayar E, Liao Z. Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 99: 70-79. PMID 28816165 DOI: 10.1016/J.Ijrobp.2017.05.022  0.347
2017 Chen Y, Lairson DR, Chan W, Huo J, Du XL. Cost-Effectiveness of Novel Agents in Medicare Patients with Multiple Myeloma: Findings from a U.S. Payer's Perspective. Journal of Managed Care & Specialty Pharmacy. 23: 831-843. PMID 28737990 DOI: 10.18553/Jmcp.2017.23.8.831  0.539
2017 Williams SB, Huo J, Dafashy TJ, Ghaffary CK, Baillargeon JG, Morales EE, Kim SP, Kuo YF, Orihuela E, Tyler DS, Freedland SJ, Kamat AM. Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment. Urologic Oncology. PMID 28647395 DOI: 10.1016/J.Urolonc.2017.05.022  0.354
2017 Xu T, Xu Y, Huo J, Yang P, Gomez DR, Liao Z. Incidental Use of Beta-Blockers, Serum VEGF, and Their Association With Disease Outcome in Patients with Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 98: 245. PMID 28587030 DOI: 10.1016/J.Ijrobp.2017.01.184  0.335
2017 Swanick CW, Eifel PJ, Huo J, Meyer LA, Smith GL. Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer. Gynecologic Oncology. PMID 28506563 DOI: 10.1016/J.Ygyno.2017.05.004  0.352
2017 Williams SB, Huo J, Kosarek CD, Chamie K, Rogers SO, Williams MA, Giordano SH, Kim SP, Kamat AM. Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer. Cancer Causes & Control : Ccc. PMID 28477210 DOI: 10.1007/S10552-017-0902-2  0.348
2017 Williams SB, Huo J, Chapin BF, Smith BD, Hoffman KE. Impact of urologists' ownership of radiation equipment in the treatment of prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 28349981 DOI: 10.1038/Pcan.2017.9  0.338
2017 Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez LM, Kim SP, Hoffman KE, Giordano SH, Chapin BF. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer. PMID 28099688 DOI: 10.1002/Cncr.30506  0.368
2017 Smith BD, Jiang J, Shih YC, Giordano SH, Huo J, Jagsi R, Momoh AO, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM. Cost and Complications of Local Therapies for Early-Stage Breast Cancer. Journal of the National Cancer Institute. 109. PMID 27678203 DOI: 10.1093/Jnci/Djw178  0.33
2017 Kosarek CD, Williams SB, Huo J, Chamie K, Smaldone MC, Fang JE, Ghaffary C, Kerr P, Ynalvez L, Kim SP, Giordano SH, Chapin BF. Overall survival advantage with radical prostatectomy for prostate cancer. Journal of Clinical Oncology. 35: 37-37. DOI: 10.1200/Jco.2017.35.6_Suppl.37  0.403
2017 Kosarek CD, Huo J, Baillargeon JG, Kuo Y, Fang JE, Ghaffary C, Kerr P, Kim SP, Orihuela E, Tyler DS, Giordano SH, Freedland SJ, Kamat AM, Williams SB. Increased utilization of advanced imaging technology and its economic impact for patients diagnosed with bladder cancer in the United States. Journal of Clinical Oncology. 35: 368-368. DOI: 10.1200/Jco.2017.35.6_Suppl.368  0.327
2017 Kerr P, Huo J, Giordano SH, Kamat AM, Morales EE, Fang JE, Ynalvez L, Dafashy T, Kosarek CD, Ghaffary C, Williams SB. Discerning predictors for gender differences in survival outcomes for patients treated for bladder cancer. Journal of Clinical Oncology. 35: 360-360. DOI: 10.1200/Jco.2017.35.6_Suppl.360  0.336
2017 Williams SB, Huo J, Dafashy T, Ghaffary C, Baillargeon JG, Morales EE, Kim SP, Kuo Y, Orihuela E, Tyler DS, Freedland SJ, Kamat AM. Survival differences among bladder cancer patients according to gender: Critical evaluation of radical cystectomy use and delay to treatment Urologic Oncology: Seminars and Original Investigations. 35: 621. DOI: 10.1016/J.Urolonc.2017.06.061  0.375
2017 Kosarek C, Huo J, Baillargeon J, Kuo Y, Fang J, Ghaffary C, Kerr P, Kim S, Orihuela E, Tyler D, Giordano S, Freedland S, Kamat A, Williams S. MP21-11 INCREASED UTILIZATION OF ADVANCED IMAGING TECHNOLOGY AND ITS ECONOMIC IMPACT FOR PATIENTS DIAGNOSED WITH BLADDER CANCER IN THE UNITED STATES Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.3273  0.333
2017 Fang JE, Huo J, Kerr P, Dafashy T, Ghaffary C, Ynalvez L, Baillargeon JG, Morales E, Kim S, O'Malley P, Kuo Y, Orihuela E, Tyler DS, Freedland SJ, Kamat AM, et al. Mp04-14 Survival Differences Among Bladder Cancer Patients According To Gender: Critical Evaluation Of Radical Cystectomy Use And Delay To Treatment The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.152  0.375
2016 Williams SB, Huo J, Chamie K, Hu JC, Giordano SH, Hoffman KE, Dinney CPN, Kamat AM, Shih YT. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer. European Urology Focus. PMID 28753760 DOI: 10.1016/J.Euf.2016.04.008  0.328
2016 Xu T, Fan J, Levy LB, Zhuang Y, Bone C, Huo J, Gomez DR, Liao Z, Hu Y. Predictive Value of Serum Hepcidin for Disease Outcome in Non-Small Cell Lung Cancer Patients Received Definitive Radio(chemo)therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E473. PMID 27674785 DOI: 10.1016/J.Ijrobp.2016.06.1817  0.342
2016 Yue J, Jeter MD, Xu T, Huo J, Pan T, Nguyen QN, Komaki RU, Gomez DR, Liao Z. Lung Dosimetry, Radiation Pneumonitis, and FDG Uptake in Patients With Stage II-III Non-Small Cell Lung Cancer Treated With Passively Scattered Proton Therapy or Intensity Modulated Pho. International Journal of Radiation Oncology, Biology, Physics. 96: E455-E456. PMID 27674736 DOI: 10.1016/J.Ijrobp.2016.06.1774  0.324
2016 Williams SB, Huo J, Smith BD, Hoffman KE. Utilization of radiotherapy for prostate cancer according to urologists’ practice patterns. Journal of Clinical Oncology. 34: 11-11. DOI: 10.1200/Jco.2016.34.2_Suppl.11  0.373
2016 Williams S, Huo J, Smith B, Hoffman K. MP25-06 UTILIZATION OF RADIOTHERAPY FOR PROSTATE CANCER ACCORDING TO UROLOGISTS’ PRACTICE PATTERNS Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.783  0.375
2015 Smith GL, Huo J, Giordano SH, Hunt KK, Buchholz TA, Smith BD. Utilization and Outcomes of Breast Brachytherapy in Younger Women. International Journal of Radiation Oncology, Biology, Physics. 93: 91-101. PMID 26279027 DOI: 10.1016/J.Ijrobp.2015.05.010  0.314
2015 Huo J, Du XL, Lairson DR, Chan W, Jiang J, Buchholz TA, Guadagnolo BA. Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma. American Journal of Clinical Oncology. 38: 235-41. PMID 23648436 DOI: 10.1097/Coc.0B013E31829378F9  0.567
2015 Huo J, Du XL, Lairson DR, Chan W, Jiang J, Buchholz TA, Ashleigh Guadagnolo B. Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma American Journal of Clinical Oncology: Cancer Clinical Trials. 38: 235-241. DOI: 10.1097/COC.0b013e31829378f9  0.518
2015 Hoffman K, Huo J, Giordano S, Smith B. Impact of Radiation Therapy Practice Setting on Prostate Cancer Treatment and Outcomes International Journal of Radiation Oncology*Biology*Physics. 93: E357. DOI: 10.1016/J.Ijrobp.2015.07.1457  0.326
2015 Mahmood U, Huo J, Koshy M, Pugh T, McGuire S, Choi S, Frank S, Lee A, Kuban D, Giordano S, Buchholz T, Smith B, Hoffman K. Image Guidance is Associated With Decreased Gastrointestinal Toxicity in Patients Receiving Definitive External Beam Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E242. DOI: 10.1016/J.Ijrobp.2015.07.1156  0.335
2014 Huo J, Giordano SH, Smith BD. Impact of radiotherapy practice structure on prostate cancer treatment and outcomes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 47. PMID 28141240 DOI: 10.1200/Jco.2014.32.30_Suppl.47  0.373
2014 Huo J, Lairson DR, Du XL, Chan W, Buchholz TA, Guadagnolo BA. Survival and cost-effectiveness of hospice care for metastatic melanoma patients. The American Journal of Managed Care. 20: 366-73. PMID 25181566  0.538
2014 Huo J, Lairson DR, Du XL, Chan W, Jiang J, Buchholz TA, Guadagnolo BA. Hospital Case Volume is Associated With Improved Survival for Patients With Metastatic Melanoma. American Journal of Clinical Oncology. PMID 24755661 DOI: 10.1097/Coc.0000000000000074  0.551
2014 Ballas L, Huo J, Guadagnolo B. Radiation Therapy Utilization in Adolescent and Young Adult Oncology Patients International Journal of Radiation Oncology*Biology*Physics. 90: S577. DOI: 10.1016/J.Ijrobp.2014.05.1738  0.379
2013 Lairson DR, Huo J, Ricks KA, Savas L, Fernández ME. The cost of implementing a 2-1-1 call center-based cancer control navigator program. Evaluation and Program Planning. 39: 51-6. PMID 23669647 DOI: 10.1016/J.Evalprogplan.2013.04.001  0.55
2013 Guadagnolo BA, Huo J, Liao KP, Buchholz TA, Das P. Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States. Cancer. 119: 1089-97. PMID 23132206 DOI: 10.1002/Cncr.27835  0.401
2013 Xu T, Gomez D, O'Reilly M, Guerrero TM, Nguyen Q, Levy LB, Huo J, Komaki R, Mohan R, Liao Z. Serum TGF-β1 and VEGF Are Associated With Tumor Burden and Tumor Response on PET to (Chemo)radiation Therapy in Patients With Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.240  0.313
Show low-probability matches.